c ballard
c ballard
Verified email at exeter.ac.uk
Title
Cited by
Cited by
Year
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ...
Neurology 65 (12), 1863-1872, 2005
5876*2005
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop
IG McKeith, D Galasko, K Kosaka, EK Perry, DW Dickson, LA Hansen, ...
Neurology 47 (5), 1113-1124, 1996
44051996
Dementia prevention, intervention, and care
G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ...
The Lancet 390 (10113), 2673-2734, 2017
25842017
Vascular cognitive impairment
J T O'Brien, T Erkinjuntti, B Reisberg, G Roman, T Sawada, L Pantoni, ...
The Lancet Neurology 2 (2), 89-98, 2003
16522003
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
EA Holmes, RC O'Connor, VH Perry, I Tracey, S Wessely, L Arseneault, ...
The Lancet Psychiatry, 2020
13512020
Putting brain training to the test
AM Owen, A Hampshire, JA Grahn, R Stenton, S Dajani, AS Burns, ...
Nature 465 (7299), 775-778, 2010
12302010
Defeating Alzheimer's disease and other dementias: a priority for European science and society
B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ...
The Lancet Neurology 15 (5), 455-532, 2016
10312016
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
CG Ballard, J Waite, J Birks
Cochrane Database of Systematic Reviews, 2006
7332006
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
C Ballard, ML Hanney, M Theodoulou, S Douglas, R McShane, ...
The Lancet Neurology 8 (2), 151-157, 2009
6752009
Donepezil and memantine for moderate-to-severe Alzheimer's disease
R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ...
New England Journal of Medicine 366 (10), 893-903, 2012
6562012
Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial
J Fossey, C Ballard, E Juszczak, I James, N Alder, R Jacoby, R Howard
Bmj 332 (7544), 756-761, 2006
6072006
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa
CG Ballard, JT O'Brien, EK Perry
The Journal of clinical psychiatry 63 (7), 553-558, 2002
5932002
Overlap between pathology of Alzheimer disease and vascular dementia.
RN Kalaria, C Ballard
Alzheimer disease and associated disorders, 1999
5601999
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies
IG McKeith, CG Ballard, RH Perry, PG Ince, JT O’brien, D Neill, K Lowery, ...
Neurology 54 (5), 1050-1058, 2000
5222000
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
BS Husebo, C Ballard, R Sandvik, OB Nilsen, D Aarsland
Bmj 343, 2011
5072011
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging
R Barber, P Scheltens, A Gholkar, C Ballard, I McKeith, P Ince, R Perry, ...
Journal of Neurology, Neurosurgery & Psychiatry 67 (1), 66-72, 1999
4911999
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
J Cummings, S Isaacson, R Mills, H Williams, K Chi-Burris, A Corbett, ...
The Lancet 383 (9916), 533-540, 2014
4842014
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
D Aarsland, C Ballard, Z Walker, F Bostrom, G Alves, K Kossakowski, ...
The Lancet Neurology 8 (7), 613-618, 2009
4842009
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
S Banerjee, J Hellier, M Dewey, R Romeo, C Ballard, R Baldwin, ...
The Lancet 378 (9789), 403-411, 2011
4702011
A comprehensive study of gray matter loss in patients with Alzheimer’s disease using optimized voxel-based morphometry
GB Karas, EJ Burton, S Rombouts, RA Van Schijndel, JT O’Brien, ...
Neuroimage 18 (4), 895-907, 2003
4582003
The system can't perform the operation now. Try again later.
Articles 1–20